Cell proliferation was determined by a BrdU assay (Roche Applied Science, Indianapolis, IN, USA) measuring the incorporation of the pyrimidine analogue, 5-bromo-2′-deoxyuridine (BrdU) during DNA ...

BrdU in single stranded DNA, free BrdU or BrdU coupled to protein carrier. S-phase of the cell cycle. Proliferation marker. Weak cross with chloro deoxyuridine but not thymidine. Comments / Questions.

Assays to assess the proliferative activity of cells grown in culture or harvested from tissue samples are a core tool for monitoring the health and growth rate of a cell population.

GVA is a high throughput cell viability assay for microbiology. Akin to the classic CFU assay, GVA measures the number of viable microbes in a sample based on counting discrete colonies. The classic ...

Each assay has specific advantages and disadvantages. For example, BrdU assays, a common DNA synthesis cell proliferation analysis method, has the advantage of single-cell resolution, but can ...

The recurrence score based on the 21-gene breast-cancer assay has been clinically useful in predicting a chemotherapy benefit in hormone-receptor–positive, human epidermal growth factor receptor ...

The Medicare decision is supported by strong evidence validating the assay's accuracy, backed by over 100 clinical studies. At the 2025 ASCO Annual Meeting, Natera presented a pan-cancer study ...

Each of these protocols is described in great detail, making this paper an excellent resource for scientists who want to attempt an assay to assess DNA damage. * Abstract from Nature Protocols ...

Tempus is presenting new data on xM for TRM at the 2025 American Society of Clinical Oncology (ASCO®) Annual Meeting, highlighting the assay’s potential to help clinicians monitor response and ...